Genzyme Corporate Search Contact Us Genzyme Websites
LysoSomal Learning
About Lysosomal Storage Disorders
Disease Classification
Presentation & Progression
Diagnosis & Testing
Disease Management
Downloads & Materials
Farber Disease (Disseminated Lipgranulomatosis)

Metabolic defect: acid ceramidase deficiency
Other sphingolipid degradation diseases: acid sphingomyelinase deficiency | Fabry | Gaucher: type I, type II, type III | GM1 gangliosidosis: type I, type II, type III | Tay-Sachs: type I, type II, type III | Sandhoff: type I | Krabbé | metachromatic leukodystrophy: type I, type II, type III

Current page:
Farber disease

Select Another Disease

Etiology & Pathogenesis

Enzyme deficiency results in accumulation in lysosomes of PAS-positive lipid consisting of ceramide, leading to cell damage with an inflammatory response.

Key Symptom Images
Swollen joints Lymphadenopathy Hepatosplenomegaly

Image Credits: Swollen joints courtesy of eMedicine.com, Inc., 2004. Lymphadenopathy courtesty of Virat Sirisanthana, MD. Hepatosplenomegaly courtesy of The National MPS Society, Inc.

Clinical Description[1] and Progression/Prognosis

A form of mucolipodosis developing soon after birth and characterized by swollen joints; formation of nodules or granules in subcutaneous tissue, around joints, on vocal cords, and in the upper airway; and lymphadenopathy. There may be several variants, ranging from mild to severe. Farber disease is a progressive disease; it often leads to death during the first few years of life. A rapidly fatal neonatal form, a form with progressive neurologic disability associated with cherry red spots, and milder phenotypes with later onset and longer survival have been observed.

Inheritance pattern: autosomal recessive
Incidence: Rare: incidence unknown
Diagnosis: Triad of subcutaneous nodules, arthritis and laryngeal involvement. Reduced acid ceramidase activity in cultured skin fibroblasts, leukocytes, amniocytes.
Conditions with similar presentations: Juvenile rheumatoid arthritis, sarcoidosis, multicentric reticulohistiocytosis.
Management: no disease-specific treatment available
Other medical care: symptom management

Signs and Symptoms

Choose a category
 
 

Musculoskeletal
Painful joint swelling and nodule formation
Nodular enlargement; joint deformity
Respiratory
Hoarseness
Breathing difficulties; respiratory distress
Recurrent pneumonias
Gastrointestinal
Feeding and swallowing difficulties
Failure to thrive
Hepatomegaly/hepatosplenomegaly in 25% of cases
Ocular
Cherry-red macular spots and retinal pigmentary mottling
Granulomas in and around the eye
Neurologic
Lack or absence of deep tendon reflexes
Signs of denervation
Impaired psychomotor development

Back to categories

Other Resources

www.emedicine.com/ped/topic1310.htm

References


1. Hensyl W, ed. Stedman’s Medical Dictionary. 25th ed. Baltimore: Williams & Wilkins; 1990; p. 885.

2. Hugo W. Moser, Thomas Linke, Anthony H. Fensom, Thierry Levade, Konrad Sandhoff. “Acid Ceramidase Deficiency: Farber Lipogranulomatosis.” The Metabolic and Molecular Bases of Inherited Disease, 8th Edition Online. McGraw-Hill. http://genetics.accessmedicine.com/server-java/Arknoid/amed/mmbid/co_chapters/ch143/ch143_p01.html Accessed September 2004.